1. Incidence of male breast cancer in Scotland over a twenty-five-year period (1992-2017)
- Author
-
Yazan Masannat, Ravi Sharma, Amanda Hagedorn, Sophie Barrack, Ehab Husain, Peng Liu, Morgan Galer, Robyn Reddington, and Valerie Speirs
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,Breast Neoplasms, Male ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Age groups ,Epidemiology ,polycyclic compounds ,Medicine ,Humans ,030212 general & internal medicine ,skin and connective tissue diseases ,neoplasms ,Aged ,Aged, 80 and over ,business.industry ,Incidence (epidemiology) ,Incidence ,General Medicine ,bacterial infections and mycoses ,medicine.disease ,Patient benefit ,Oncology ,Scotland ,030220 oncology & carcinogenesis ,Male breast cancer ,bacteria ,Surgery ,Rural area ,business ,Demography - Abstract
Male breast cancer (MBC) accounts for around 1% of all breast cancers diagnosed. There are inconsistent reports on the incidence of MBC which some propose may be rising. Here, for the first time, the incidence of MBC in Scotland over 25 years from 1992 to 2017 was examined through interrogating the Information Services Division Scotland database. Results showed MBC incidence rose with age, peaking in the 65–70 and 75–79 age groups. Both the total number and the age-adjusted incidence of MBC increased in Scotland since 1992. This rising trend was most clear in the North of Scotland. Interestingly a higher MBC incidence in some rural areas was also observed. Our findings emphasise the need for a better understanding of MBC risk factors so that improved prevention policies can be applied for patient benefit.
- Published
- 2019